Pharmadrug

Pharmadrug is a pharmaceutical company focused on the research and development of controlled substances and natural medicines including psychedelics and cannabis.

Pharmadrug

Pharmadrug is currently carrying out in vitro studies using their short-list of DMT-analogue molecules which they hope can be used to treat eye diseases.

Additionally, Pharmadrug owns Sairiyo Therapeutics, a biotech company that specializes in repurposing and reformulating psychedelics with the goal of bringing them through regulatory approval.

Their Pharamdrug Production GmbH subsidiary is a German pharmaceutical distributor with a Schedule I EU narcotics license and EuGMP supply chain certification allowing for the importation, packaging, and distribution of controlled substances under its own brand to pharmacies in Germany and throughout the European Union.